Rinah Yamamoto


Assessing Suicide Risk in Clinical Trials: The Patient Knows Best

January 22, 2020

During clinical trials of pharmaceutical treatments, sponsors and CROs need to detect possible suicidal ideation and behavior related to their drug during baseline assessments, and throughout treatment as well as during the follow up phases.